RNA, U6 small nuclear 1028, pseudogene (RNU6-1028P)

RNU6-1028P, also known as "RNA, U6 small nuclear 1028, pseudogene," is annotated as a pseudogene corresponding to the U6 small nuclear RNA (U6 snRNA) family. U6 snRNA is an essential non-coding RNA that plays a catalytic and structural role in the spliceosome, which is responsible for removing introns from pre-mRNA in eukaryotic cells[1][3]. However, pseudogenes such as RNU6-1028P are genomic copies with sequence similarity to the functional U6 snRNA gene but are typically disrupted by mutations, insertions, or deletions that prevent them from producing a functional RNA molecule[2]. Most pseudogenes are regarded as non-functional, although some are transcribed and may act via RNA-based mechanisms; there is currently no evidence that RNU6-1028P has a defined biological activity or functions as a therapeutic target[2]. Key points: - RNU6-1028P is a pseudogene of U6 snRNA, not a protein-coding gene, receptor, or enzyme. - It is not considered a therapeutic target and has no established function as a biomarker, drug target, or disease gene[2][3]. - Pseudogenes of snRNAs are common in the genome and reflect past duplication or retrotransposition events[3][4][5]. - There is no evidence of known drug, disease association, or clinical significance for RNU6-1028P in the current literature. Explanation regarding errors (is_incorrect: true): This entity does not represent a canonical therapeutic target (like a receptor, enzyme, or transporter); it is a pseudogene and commonly not functional or targeted in drug discovery or clinical practice[2][3]. Its listing as a “target” is thus incorrect, and there is no evidence supporting therapeutic relevance. If structured information on U6 snRNA is needed, data should focus on the functional U6 snRNA gene, not this pseudogene copy.

Other names

RNU6-1028PU6 snRNA pseudogene 1028U6 RNA pseudogene 1028